In reply-regarding L-carnitine and cardiovascular disease

Affiliations

Comment

James J DiNicolantonio et al. Mayo Clin Proc. 2013 Aug.

. 2013 Aug;88(8):900-1.

doi: 10.1016/j.mayocp.2013.06.010.

¹ Wegmans Pharmacy, Ithaca, NY; Mid America Heart Institute, University of Missouri, Kansas City, MO.

No abstract available

Comment on

L-carnitine in the secondary prevention of cardiovascular disease: systematic review and meta-analysis.
DiNicolantonio JJ, Lavie CJ, Fares H, Menezes AR, O'Keefe JH. DiNicolantonio JJ, et al. Mayo Clin Proc. 2013 Jun;88(6):544-51. doi: 10.1016/j.mayocp.2013.02.007. Epub 2013 Apr 15. Mayo Clin Proc. 2013. PMID: 23597877
Regarding L-carnitine and cardiovascular disease.
Thompson WG, Hensrud DD, Murad MH. Thompson WG, et al. Mayo Clin Proc. 2013 Aug;88(8):899-900. doi: 10.1016/j.mayocp.2013.06.011. Mayo Clin Proc. 2013. PMID: 23910416 No abstract available.